- Nachrichtendetail
-
04.04.2024 12:53:46 - dpa-AFX: *MERCK INITIATES PHASE 3 TRIAL OF MK-1084 WITH FOR FIRST-LINE TREATMENT OF CERTAIN PATIENTS WITH METASTATIC NSCLC
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 129,290 | 14.06.24 19:56:57 | -0,080 | -0,06% | 129,290 | 129,310 | 129,160 | 129,370 |
